Table 4 Medication differences in minimum spanning tree measures.

From: Functional brain networks in the schizophrenia spectrum and bipolar disorder with psychosis

 

df

F

p

 

Mean

SE

Antipsychotic medication effects on MST measures

Connectivity strength

 Group

1126

0.524

0.470

   

  BD/AP

    

0.641

0.006

  BD/nAP

    

0.635

0.006

Diameter

 Group

1126

0.817

0.368

   

  BD/AP

    

0.112

0.002

  BD/nAP

    

0.109

0.002

Kappa

 Group

1126

<0.001

0.990

   

  BD/AP

    

2.802

0.013

  BD/nAP

    

2.802

0.013

Leaf fraction

 Group

1126

0.008

0.929

   

  BD/AP

    

0.467

0.003

  BD/nAP

    

0.467

0.003

Lithium effects on MST measures

Connectivity Strength

 Group

1131

3.702

0.057

   

  BD/li+

    

0.632

0.005

  BD/li−

    

0.648

0.008

Diameter

 Group

1131

1.131

0.290

   

  BD/li+

    

0.109

0.002

  BD/li−

    

0.113

0.002

Kappa

 Group

1131

0.972

0.326

   

  BD/li+

    

2.800

0.013

  BD/li−

    

2.819

0.014

Leaf fraction

 Group

1131

0.150

0.699

   

  BD/li+

    

0.466

0.003

  BD/li−

    

0.469

0.003

  1. Group differences were tested with ANCOVAs with age, sex, and education as covariates and the Benjamini–Hochberg FDR correction for multiple testing.
  2. HC healthy controls, SCP subclinical psychosis, SCZ schizophrenia spectrum disorder, BD bipolar disorder with psychosis, BD/AP bipolar disorder with antipsychotic use, BD/nAP bipolar disorder without antipsychotic use, BD/li+ bipolar disorder with lithium use, BD/li− bipolar disorder without lithium use.